Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LKA GOLD Inc /DE/LKAI · Entity 166501 | 10% owner | November 20, 2017 | January 26, 2018 |
| ORAGENICS INCOGEN · Entity 8495 | Director | December 11, 2025 | December 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LKA GOLD Inc /DE/
Report date November 20, 2017 · Filed January 26, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common stockSEC Table I · non-derivative | Direct | 2,171,400 |
Ending reported balance
After 2018-01-26 transaction · row 10
10 source rows · reconciled sequenceRow 1 · 2017-11-20 · Purchase · Acquired 6,000 · Balance 2,071,700 Row 2 · 2017-11-21 · Purchase · Acquired 5,000 · Balance 2,076,700 Row 3 · 2017-11-22 · Purchase · Acquired 5,100 · Balance 2,081,800 Row 4 · 2017-11-24 · Purchase · Acquired 2,000 · Balance 2,083,800 Row 5 · 2017-11-27 · Purchase · Acquired 9,000 · Balance 2,092,800 Row 6 · 2017-11-28 · Purchase · Acquired 6,400 · Balance 2,099,200 Row 7 · 2017-11-29 · Purchase · Acquired 22,000 · Balance 2,121,200 Row 8 · 2017-11-30 · Purchase · Acquired 10,200 · Balance 2,131,400 Row 9 · 2018-01-23 · Purchase · Acquired 20,000 · Balance 2,151,400 Row 10 · 2018-01-26 · Purchase · Acquired 20,000 · Balance 2,171,400 |
ORAGENICS INC
Report date December 11, 2025 · Filed December 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Employee Director Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.93 · Expires 2035-12-11 | Direct | 125,000 |
Reported balance
After 2025-12-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-11 · Grant · Acquired 125,000 · Balance 125,000 F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HELIOS TECHNOLOGIES, INC.
Report date August 09, 2019 · Filed August 09, 2019
Section 16 reporting ended · disclosed 2019-08-09. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2025 Filed Dec 15, 2025 21:19 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001234880-25-000002 · primary_doc.xml · derivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2035-12-11 F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 21:05 UTC | ORAGENICS INC OGEN · Entity 8495 | ConversionSeries B Convertible Preferred Stock · Derivative | 1,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-049989 · ownership.xml · derivative · entry 3 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share. F3 · price: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share. F3 · derivative.exercise_date: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share. F3 · derivative.expiration_date: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share. F2 · derivative.underlying_shares: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B. F1 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 21:05 UTC | ORAGENICS INC OGEN · Entity 8495 | ConversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-049989 · ownership.xml · nonDerivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 23,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. F2 · shares: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B. F1 · price: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. F2 · price: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B. F3 · price: The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share. F1 · balance_after: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. F2 · balance_after: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B. F1 · ownership.direct: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. F2 · ownership.direct: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B. F1 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. F2 · ownership.nature: Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B. Read SEC document |
| September 19, 2024 Filed Sep 21, 2024 01:15 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001493152-24-037731 · ownership.xml · derivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2034-09-19 F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 20:30 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-027579 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,689 F1 · shares: Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months. F2 · balance_after: Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023. Read SEC document |
| August 08, 2023 Filed Jan 22, 2024 22:30 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-003332 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,940 F1 · balance_after: This Form 5 is being filed by the Reporting Person to correct an administrative error, which incorrectly reported the number of shares of Common Stock as beneficially owned by the Reporting Person. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 21:20 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 42,357 | $0.11 | $4,468.66 |
DisclosureSEC source: 0001493152-23-000130 · ownership.xml · nonDerivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,102,295 F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 21:20 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 36,648 | $0.11 | $3,884.69 |
DisclosureSEC source: 0001493152-23-000130 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,191 F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.direct: Shares owned directly by Robert C. Koski, a director of the Company. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:05 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 140,497 | $0.18 | $24,699.37 |
DisclosureSEC source: 0001493152-22-035732 · ownership.xml · nonDerivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,144,652 F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 and $0.1600 to $0.1800 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 21:15 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 4,503 | $0.18 | $788.03 |
DisclosureSEC source: 0001493152-22-035570 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,310,149 F1 · price: The price reported in Column 4 was the weighted average price on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:05 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 25,000 | $0.18 | $4,375.00 |
DisclosureSEC source: 0001493152-22-035732 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,285,149 F1 · price: The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 and $0.1600 to $0.1800 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 09, 2022 Filed Dec 12, 2022 21:22 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 48,795 | $0.20 | $9,612.62 |
DisclosureSEC source: 0001493152-22-035184 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,314,652 F1 · price: The price reported in Column 4 was the weighted average price on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1750 to $0.2000 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 21:14 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 13,036 | $0.20 | $2,607.20 |
DisclosureSEC source: 0001493152-22-035043 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,363,447 F1 · price: The prices reported in Column 4 are weighted average prices on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1901 to $0.2000 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| November 30, 2022 Filed Dec 1, 2022 21:08 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 200,000 | $0.19 | $38,220.00 |
DisclosureSEC source: 0001493152-22-034167 · ownership.xml · nonDerivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,376,483 F1 · price: The prices reported in Column 4 are weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1900 to $0.2100 and $0.1800 to $0.2000 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 21:08 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 200,000 | $0.19 | $38,460.00 |
DisclosureSEC source: 0001493152-22-034167 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,576,483 F1 · price: The prices reported in Column 4 are weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1900 to $0.2100 and $0.1800 to $0.2000 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:42 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 220,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-22-021024 · ownership.xml · derivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2032-07-29 F1 · security: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · derivative.underlying_shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · balance_after: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:29 UTC | ORAGENICS INC OGEN · Entity 8495 | PurchaseCommon Stock | 799,100 | $0.47 | $378,773.40 |
DisclosureSEC source: 0001493152-22-000118 · ownership.xml · nonDerivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,776,483 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.44 to $0.48. F3 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 21:29 UTC | ORAGENICS INC OGEN · Entity 8495 | PurchaseCommon Stock | 200,900 | $0.45 | $90,364.82 |
DisclosureSEC source: 0001493152-22-000118 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 977,383 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.43 to $0.46. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F3 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 22:09 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001493152-21-031893 · ownership.xml · derivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-12-16 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:35 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001493152-21-004423 · ownership.xml · derivative · entry 4 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2031-02-18 F1 · security: Shares owned directly by Robert C. Koski, a director of the Company. F4 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F4 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F4 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. Read SEC document |
| January 02, 2021 Filed Feb 19, 2021 21:35 UTC | ORAGENICS INC OGEN · Entity 8495 | GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-004423 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,839 F1 · ownership.direct: Shares owned directly by Robert C. Koski, a director of the Company. Read SEC document |
| December 22, 2020 Filed Dec 23, 2020 23:15 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 310,000 | $0.43 | $132,432.00 |
DisclosureSEC source: 0001493152-20-024267 · ownership.xml · nonDerivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 776,483 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| April 24, 2020 Filed Dec 23, 2020 23:15 UTC | ORAGENICS INC OGEN · Entity 8495 | GiftCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-024267 · ownership.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,839 F1 · ownership.direct: Shares owned directly by Robert C. Koski, a director of the Company. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:25 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 156,540 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001493152-20-001790 · ownership.xml · derivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,540 Underlying: Common Stock · 156,540 shares Expires 2030-02-05 F2 · security: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020. F2 · shares: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020. F2 · derivative.underlying_shares: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020. F2 · balance_after: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:25 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 156,540 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001493152-20-001790 · ownership.xml · derivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,540 Underlying: Common Stock · 156,540 shares Expires 2030-02-05 F1 · security: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately. F1 · shares: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately. F1 · balance_after: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately. Read SEC document |
| December 30, 2019 Filed Dec 31, 2019 21:10 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 100,000 | $0.53 | $52,610.00 |
DisclosureSEC source: 0001493152-19-019927 · ownership.xml · nonDerivative · entry 3 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,086,483 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.52 to $0.535. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| December 27, 2019 Filed Dec 31, 2019 21:10 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 100,000 | $0.52 | $51,670.00 |
DisclosureSEC source: 0001493152-19-019927 · ownership.xml · nonDerivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,186,483 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.51 to $0.5239. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 20:57 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | SaleCommon Stock | 3,100 | $49.03 | $151,995.17 |
DisclosureSEC source: 0001234878-19-000006 · primary_doc.xml · nonDerivative · entry 1 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,152 F1 · kind: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019. F2 · price: The range of prices for the transactions reported is $49.00 - $49.1050. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| July 24, 2019 Filed Jul 25, 2019 18:29 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | SaleCommon Stock | 5,000 | $48.00 | $240,022.00 |
DisclosureSEC source: 0001234878-19-000005 · primary_doc.xml · nonDerivative · entry 1 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,252 F1 · kind: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2019. F2 · price: The range of prices for the transactions reported is $48.00 - $48.0450. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| June 27, 2019 Filed Jul 2, 2019 00:29 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | SaleCommon Stock | 2,500 | $44.32 | $110,800.00 |
DisclosureSEC source: 0001234880-19-000007 · primary_doc.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · 10% owner KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 F1 · price: The range of prices for the transactions reported is $44.28 - $44.35. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Shares owned directly by Robert C. Koski. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 23:11 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | SaleCommon Stock | 2,500 | $45.72 | $114,300.00 |
DisclosureSEC source: 0001234878-19-000004 · primary_doc.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · 10% owner KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 F1 · price: The range of prices for the transactions reported is $45.65 - $45.75. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Shares owned directly by Robert C. Koski. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 21:13 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | SaleCommon Stock | 5,000 | $47.03 | $235,166.00 |
DisclosureSEC source: 0001234878-19-000003 · primary_doc.xml · nonDerivative · entry 1 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,252 F1 · price: The range of prices for the transactions reported is $47.00 - $47.14. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 21:06 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 156,540 | Not disclosed Strike: $0.48 | Not disclosed |
DisclosureSEC source: 0000899243-19-017959 · doc4.xml · derivative · entry 7 KOSKI ROBERT C · CIK 0001234880 · Director KOSKI CHRISTINE L · CIK 0001234878 · Affiliate KOSKI BEVERLY · CIK 0001234877 · Affiliate KOSKI FAMILY LP · CIK 0001234879 · Affiliate KOSKI THOMAS L · CIK 0001234881 · Affiliate Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,540 Underlying: Common Stock · 156,540 shares Expires 2029-06-20 F8 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date. F8 · price: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date. F8 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date. F8 · derivative.underlying_shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date. F8 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 15:30 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | SaleCommon Stock | 2,500 | $45.59 | $113,976.00 |
DisclosureSEC source: 0001234880-19-000006 · primary_doc.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · 10% owner KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 F1 · price: The range of prices for the transactions reported is $45.50 - $45.67. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Shares owned directly by Robert C. Koski. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 18:26 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | SaleCommon Stock | 6,792 | $46.59 | $316,416.19 |
DisclosureSEC source: 0001234878-19-000002 · primary_doc.xml · nonDerivative · entry 3 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,252 F3 · price: The range of prices for the transactions reported is $46.33 - $46.71. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 18:26 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | SaleCommon Stock | 18,908 | $45.71 | $864,280.90 |
DisclosureSEC source: 0001234878-19-000002 · primary_doc.xml · nonDerivative · entry 2 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,044 F2 · price: The range of prices for the transactions reported is $45.33 - $46.3250. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 18:23 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | SaleCommon Stock | 4,300 | $45.03 | $193,630.72 |
DisclosureSEC source: 0001234880-19-000005 · primary_doc.xml · nonDerivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · 10% owner KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,202 F3 · price: The range of prices for the transactions reported is $45.00 - $45.47. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F4 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 18:26 UTC | HELIOS TECHNOLOGIES, INC. HLIO · Entity 4399 | GrantCommon Stock | 750 | $44.73 | $33,547.50 |
DisclosureSEC source: 0001234878-19-000002 · primary_doc.xml · nonDerivative · entry 1 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,952 F1 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 18:23 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | SaleCommon Stock | 2,500 | $45.12 | $112,811.25 |
DisclosureSEC source: 0001234880-19-000005 · primary_doc.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · 10% owner KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · price: The range of prices for the transactions reported is $45.02 - $45.22. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Shares owned directly by Robert C. Koski. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 16:55 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | SaleCommon Stock | 2,500 | $45.16 | $112,892.00 |
DisclosureSEC source: 0001234880-19-000004 · primary_doc.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · 10% owner KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 F1 · price: The range of prices for the transactions reported is $45.112 - $45.189. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Shares owned directly by Robert C. Koski. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 16:04 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | SaleCommon Stock | 10,000 | $46.52 | $465,241.00 |
DisclosureSEC source: 0001234880-19-000003 · primary_doc.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · 10% owner KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 F1 · price: The range of prices for the transactions reported is $46.23 - $46.76. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Shares owned directly by Robert C. Koski. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 21:09 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | GrantCommon Stock | 750 | $48.59 | $36,442.50 |
DisclosureSEC source: 0001234878-19-000001 · primary_doc.xml · nonDerivative · entry 1 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,502 F1 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 14:24 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | SaleCommon Stock | 2,500 | $50.15 | $125,385.00 |
DisclosureSEC source: 0001234880-19-000002 · primary_doc.xml · nonDerivative · entry 2 KOSKI ROBERT C · CIK 0001234880 · 10% owner KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 F2 · price: The range of prices for the transactions reported is $50.00 - $50.36. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: Shares owned directly by Robert C. Koski. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 14:24 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | SaleCommon Stock | 2,500 | $49.25 | $123,125.00 |
DisclosureSEC source: 0001234880-19-000002 · primary_doc.xml · nonDerivative · entry 1 KOSKI ROBERT C · CIK 0001234880 · 10% owner KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,500 F1 · ownership.direct: Shares owned directly by Robert C. Koski. Read SEC document |
| December 18, 2018 Filed Dec 20, 2018 16:55 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | GrantCommon Stock | 750 | $36.43 | $27,322.50 |
DisclosureSEC source: 0001234878-18-000012 · primary_doc.xml · nonDerivative · entry 1 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,752 F1 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 20:07 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0000899243-18-025660 · doc4.xml · derivative · entry 7 KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI ROBERT C · CIK 0001234880 · Director · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI CHRISTINE L · CIK 0001234878 · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2028-09-27 F8 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended in connection with service to the Company as a director. The options vest immediately. The option exercise price is the closing price on the date of the grant, September 27, 2018. F8 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended in connection with service to the Company as a director. The options vest immediately. The option exercise price is the closing price on the date of the grant, September 27, 2018. Read SEC document |
| September 21, 2018 Filed Sep 24, 2018 21:13 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | SaleCommon Stock | 4,580 | $58.03 | $265,796.64 |
DisclosureSEC source: 0001234878-18-000010 · primary_doc.xml · nonDerivative · entry 4 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,252 F1 · kind: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2018. F6 · price: The range of prices for the transactions reported is $58.00 - $58.11. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| September 21, 2018 Filed Sep 24, 2018 21:13 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | SaleCommon Stock | 5,900 | $57.54 | $339,493.08 |
DisclosureSEC source: 0001234878-18-000010 · primary_doc.xml · nonDerivative · entry 3 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,832 F1 · kind: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2018. F5 · price: The range of prices for the transactions reported is $57.00 - $57.76. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 19:48 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | GrantCommon Stock | 750 | $57.56 | $43,170.00 |
DisclosureSEC source: 0001234878-18-000011 · primary_doc.xml · nonDerivative · entry 1 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,002 F1 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
| September 20, 2018 Filed Sep 24, 2018 21:13 UTC | HELIOS TECHNOLOGIES, INC. SNHY · Entity 4399 | SaleCommon Stock | 5,970 | $56.92 | $339,784.94 |
DisclosureSEC source: 0001234878-18-000010 · primary_doc.xml · nonDerivative · entry 2 KOSKI CHRISTINE L · CIK 0001234878 · Director · 10% owner KOSKI BEVERLY · CIK 0001234877 · 10% owner KOSKI FAMILY LP · CIK 0001234879 · 10% owner KOSKI THOMAS L · CIK 0001234881 · 10% owner KOSKI ROBERT C · CIK 0001234880 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,732 F1 · kind: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2018. F4 · price: The range of prices for the transactions reported is $56.51 - $57.40. The undersigned hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Shares owned directly by Christine L. Koski. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.